Key facts
- This page summarizes Daniel E. Geffken's Form 4 filing for CalciMedica, Inc. (CALC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 May 2024, 19:47.
Daniel E. Geffken - 17 May 2024 Form 4 Insider Report for CalciMedica, Inc. (CALC)
- Reporting relationship
- Interim CFO
- Issuer ticker
- CALC
- Reported as of
- 17 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 May 2024, 19:47:02 UTC
- Prior SEC filing
- 16 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Dunn, Esq., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Geffken filed Form 4 for CalciMedica, Inc. (CALC) on 20 May 2024.
Change
- Previous filing in this sequence was filed on 16 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CALC
transaction
Derivative
Warrant
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 17 May 2024
- Ownership
- By SG Dan Equity Holdings, LLC
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $5.45
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Beginning on May 17, 2024, the shares subject to the warrant shall vest and be exercisable in a series of twelve (12) successive equal monthly installments.